Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT201104256280N1Phase 3Completed
Phase 3 trial of tranexamic acid in femoral fracture, sponsored by Guilan University of Medical Sciences. Primary endpoint: Intraoperative bleeding volume. Started Jul 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT201104256280N1.